US 12304969
Factor XI A2 domain-binding antibodies and methods of use thereof
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 12304969 (Factor XI A2 domain-binding antibodies and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K39/3955, A61P